Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma exosomal miR‐106a‐5p expression in myasthenia gravis

31 Dec 2019

Abstract excerpt

BACKGROUND: Exosomal miRNA expression for myasthenia gravis (MG) has not been studied. METHODS: Plasma samples from 92 patients with MG and 49 age-matched healthy controls (HCs) were screened (by means of deep sequencing and quantitative real-time polymerase chain reaction) for differentially expressed exosomal microRNA (miRNAs). miR-106a-5p was chosen to further verify because it is reportedly involved in MG...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inflammatory Myopathies and Dermatomyositis
Share to Myasthenia Gravis and Thymoma
Share to Peripheral Neuropathies and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31889318
DOI: 10.1002/mus.26785

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma exosomal miR‐106a‐5p expression in myasthenia gravisPMID 31889318Read ↗

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized MedicineSemantic proximity Read ↗

Emerging Roles of Dysregulated MicroRNAs in Myasthenia GravisSemantic proximity Read ↗

A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis.Semantic proximity Read ↗

Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravisSemantic proximity Read ↗

Small extracellular vesicle microRNAs in pediatric myasthenia gravis plasma and skeletal muscleSemantic proximity Read ↗

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.Semantic proximity Read ↗

Competitive endogenous RNA network and pathway-based analysis of LncRNA single-nucleotide polymorphism in myasthenia gravis.Semantic proximity Read ↗

Identifying a polymorphic 'switch' that influences miRNAs' regulation of a myasthenia gravis risk pathway.Semantic proximity Read ↗

Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAsSemantic proximity Read ↗

Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analysesSemantic proximity Read ↗

Non-coding RNA and its network in the pathogenesis of Myasthenia GravisSemantic proximity Read ↗

Circulating microRNAs as potential biomarkers in myasthenia gravis patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.